Management of Severe Perimenopausal Bleeding with Adenomyosis

Initial Assessment and Stabilization

The American College of Cardiology recommends immediate assessment of hemodynamic stability, pregnancy status, and hemoglobin levels to quantify anemia in patients with severe perimenopausal bleeding, with bleeding saturating a large pad/tampon hourly for ≥4 hours warranting urgent evaluation 3
Endometrial biopsy is recommended if presentation raises concern for other pathology, with the American College of Radiology suggesting its use in evaluating patients with severe bleeding 4

The American College of Obstetricians and Gynecologists recommends the levonorgestrel-releasing intrauterine device (LNG-IUD 20 μg/d) as first-line therapy, reducing menstrual blood loss by 71-95% with efficacy comparable to endometrial ablation 1, 2
The LNG-IUD acts primarily at the endometrial level with minimal systemic progesterone absorption, providing long-term symptom control while preserving the uterus 3, 1
Follow-up at 3 months to assess symptom improvement is recommended, with the American College of Obstetricians and Gynecologists suggesting this timeframe for evaluation 2

Combined oral contraceptives reduce painful and heavy menstrual bleeding, though less effective than LNG-IUD, according to the American College of Obstetricians and Gynecologists 1, 2
GnRH antagonists are highly effective for heavy menstrual bleeding even with concomitant adenomyosis, as recommended by the American College of Obstetricians and Gynecologists 1, 2
Cyclic oral progestin reduces bleeding by 87%, often resulting in only light bleeding, as suggested by the American Heart Association 3

Tranexamic acid provides significant reduction in menstrual blood loss as a nonhormonal alternative, according to the American College of Obstetricians and Gynecologists 5
NSAIDs can reduce menstrual blood loss, though their use should be avoided in women with cardiovascular disease, as recommended by the American Heart Association 5, 3

High-dose oral or injectable progestin-only medications are recommended for short-term control of severe bleeding with hemodynamic instability, as suggested by the American College of Cardiology 3
Concurrent iron supplementation is recommended, with the American College of Radiology suggesting its use in patients with severe bleeding 5
Consider hospital admission for monitoring and blood transfusion if needed, as recommended by the American College of Radiology 4

Uterine artery embolization (UAE) provides short-term improvement in 94% of patients and long-term improvement in 85% of patients with symptom control up to 7 years, according to the American College of Obstetricians and Gynecologists 1, 2
Endometrial ablation offers greater long-term efficacy than oral medical treatment, reducing pregnancy risk while managing bleeding, as recommended by the American Heart Association 3

Hysterectomy should be offered when medical and interventional therapies fail, providing definitive resolution with patient satisfaction rates up to 90%, as recommended by the American College of Obstetricians and Gynecologists 5
Vaginal or laparoscopic routes are preferred over abdominal approach, with the American College of Obstetricians and Gynecologists suggesting these routes for hysterectomy 2

No medical therapy eradicates adenomyosis lesions; all provide only temporary symptom relief with rapid recurrence after discontinuation, as noted by the American College of Obstetricians and Gynecologists 2
In perimenopausal women on antiplatelet therapy, hormonal therapy requires careful clinical judgment, as recommended by the American Heart Association 3
GnRH agonists require add-back therapy with long-term use to prevent bone mineral loss, as suggested by the American College of Obstetricians and Gynecologists 2
Fertility is suppressed during GnRH agonist/antagonist treatment, according to the American College of Obstetricians and Gynecologists 5